• Subscribe Now
  • Cannabis News
    • Business News
    • Adult Use
    • Medical
    • Policy & Legislation
    • Hemp & CBD
    • International
  • Insights
    • Featured Announcements
    • Q&A Interviews
    • Podcasts
    • Vocabulary
  • Resources
    • Service Providers
    • Cannabis Brands
    • Dispensaries
    • Upcoming Events
  • Connect
    • Become a Subscriber
    • About Ganjapreneur
    • Contact Us
    • Partner With Us
    • Submit an Announcement
  • Subscriber Login
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube
Skip to content
  • Subscriber Login
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube
Ganjapreneur

Ganjapreneur

Cannabis Business Information Since 2014

  • Cannabis News
    • Business News
    • Adult Use
    • Medical
    • Policy & Legislation
    • Hemp & CBD
    • International
  • Insights
    • Featured Announcements
    • Q&A Interviews
    • Podcasts
    • Vocabulary
  • Resources
    • Service Providers
    • Cannabis Brands
    • Dispensaries
    • Upcoming Events
  • Connect
    • Become a Subscriber
    • About Ganjapreneur
    • Contact Us
    • Partner With Us
    • Submit an Announcement
  • Subscribe Now
  • News Categories
  • Latest News
  • Business
  • Policy & Legislation
  • Medical Cannabis
  • Adult Use
  • Hemp & CBD
Home //
FDA

The US Food and Drug Administration (FDA) is currently working to understand how cannabis and isolated CBD products can be useful to American citizens. There are robust statistics and stories emerging as the FDA conducts cannabis research. Read more about these details in the following stories, and sign up for our newsletter to be the first to find out when news hits the wire.


FDA Says CBD Should Be Descheduled

Cannabis PolicyMedical CannabisNews Briefs
by Guest ContributorOctober 2, 2018July 3, 2025
Green

First FDA-Approved CBD Medication to Cost More than $32,000 Per Year

Cannabis Industry NewsMedical CannabisNews Briefs
by Graham AbbottAugust 9, 2018July 3, 2025
|

California to Block Hemp-Derived CBD From All Food Products

Hemp Industry NewsNews Briefs
by Graham AbbottJuly 17, 2018July 3, 2025

FDA Approves CBD-Based Epidiolex

Cannabis PolicyMedical CannabisNews Briefs
by Graham AbbottJune 25, 2018July 3, 2025
|

McConnell’s Bill Would Normalize the Hemp Industry

Cannabis PolicyHemp Industry NewsNews Briefs
by TG BranfaltApril 20, 2018July 3, 2025

Epidiolex Receives Initial Recommendation from FDA Committee

Cannabis PolicyMedical CannabisNews Briefs
by Graham AbbottApril 20, 2018July 3, 2025
A woman holds up a small

NORML Launches Website to Send FDA Public Comments Regarding Cannabis Rescheduling

Cannabis PolicyInternational Cannabis NewsMarijuana CultureNews Briefs
by TG BranfaltApril 11, 2018July 3, 2025
A full pint of beer sits on a wooden surface.

Massachusetts Alcohol Regulators Block CBD Beer Claiming FDA Rules Violation

Adult UseCannabis PolicyHemp Industry NewsNews Briefs
by TG BranfaltMarch 26, 2018July 3, 2025

MMJ Research Firm Secures Production License from Health Canada; One Step Closer to FDA Approval

Cannabis Industry NewsMedical CannabisNews Briefs
by TG BranfaltMarch 14, 2018July 3, 2025
Cannabis clones inside of a commercial grow operation.

FDA Requests Public Comments on Therapeutic Value of CBD

Cannabis PolicyMarijuana News BriefsNews Briefs
by Graham AbbottSeptember 4, 2017July 3, 2025

Posts pagination

Newer posts 1 … 5 6 7 8 Older posts

Featured Subscriber:

Ganjapreneur is made possible by our business subscribers. Subscribe today

Cannabis News

  • Latest News
  • Business
  • Policy & Legislation
  • Medical Cannabis
  • Adult Use
  • Hemp & CBD

Insights

  • Podcasts
  • Q&A Interviews
  • Featured Announcements
  • Science & Research
  • Vocabulary

Resources

  • Services & Equipment
  • Cannabis Brands
  • Dispensaries
  • Upcoming Events

US Markets

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Iowa
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • Washington DC
  • West Virginia
  • Wisconsin
  • Wyoming

International

  • View All
  • Amsterdam
  • Asia
  • Argentina
  • Australia
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • Guam
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Morocco
  • New Zealand
  • Puerto Rico
  • Netherlands
  • South Africa
  • Spain
  • Switzerland
  • Thailand
  • Ukraine
  • Uruguay

Ganjapreneur

Grassroots cannabis business intelligence.

  • About us
  • Contact us
  • Become a subscriber
  • Partner with us
© 2026 Ganjapreneur Site by Bluedream
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube

All rights reserved. // Terms of Use // Advertising Policy // Privacy Policy


DISCLAIMER: Ganjapreneur.com is intended as an educational resource for law-abiding professionals and those who are curious about entrepreneurial and/or investment opportunities in emerging markets. We do not offer investment advice, and we encourage all visitors and readers to do their own due dilligence before investing in any of the companies or markets that we write about. Be advised that possessing, using, distributing and selling cannabis are all federal crimes in the United States of America and the articles, pages, links, and other types of information on this site are not intended to assist you in violating federal law. Ganjapreneur.com and all associated entities and individuals are not responsible for third party content and/or links published on this website.